Archive of the Category 'Events'
Dr. Della Valle Part of USA Faculty for Upcoming AOA Meeting
Dr. Della Valle will be be part of the USA faculty for the upcoming Australian Orthopaedic Association COE meeting – ‘Precision Hip and Knee Surgery – Evaluation, Planning and Delivery’ on June 17-18.
His presentation is entitled ‘Is outpatient arthroplasty safe?’. Adolph Lombardi, Jonathan Vigdorchik, Stefan Kreuzer and Antonia Chen will also be presenting.
Learn more about the USA faculty at aoa.org.au/coe-faculty. Register and see the program at aoa.org.au/COE-June
Dr. Della Valle on NovApproach Spine’s OrthoChallenge Selection Panel
NovApproach Spine’s CEO Raymond Cloutier is asking for surgeons, physical therapists and engineers to submit innovative products and services to better support these patients during this challenging time and reduce their risk for COVID-19. Dr. Della Valle is a part of the selection panel.
Learn more at Orthopedics This Week: https://ryortho.com/breaking/are-you-up-for-an-orthochallenge-to-kick-covid-19s-a/
Dr. Della Valle Recognized by Arthritis Foundation
Dr. Della Valle, Immediate Past President of the American Association of Hip & Knee Surgerons, received the Rowland W Chang, MD, MPH Award of Excellence at the Arthritis Foundation Freedom of Movement Gala in Chicago last weekend. Dr. Della Valle was recognized for his years of commitment to the Arthritis Foundation and its mission to fight and find a cure for arthritis. “I could not think of anyone more deserving of this award than Craig. He has an intellectual curiosity, drive and passion that is unparalleled. We are fortunate to have him as a part of our community, and I am excited to see where he will continue to lead us into the future,” said Denis Nam, MD, MSc, AAHKS member and Arthritis Foundation Board member who presented Dr. Della Valle with the award.
Dr. Della Valle at the ISHKS in Bangalore, India
Dr. Della Valle was invited to speak at the Indian Society of Hip and Knee Surgery in Bangalore, India, from April 12-14, 2019.
From Dr. Della Valle:
“I Had the great pleasure of traveling to India along with AAHKS past president Bill Jiranek to present at the Indian Society of Hip and Knee Surgery which was attended by approximately 400 surgeons who specialize in hip and knee surgery. Over three days I engaged in approximately 10 lecturers ranging from primary to revision hip and knee arthroplasty. The hospitality was incredible and the scientific content of the meeting impressive. It was an honor to be a part of their meeting and to share our work and experiences with them!”
Click here for an article on the meeting from AAHKS. To learn more about the ISHKS, visit ishks.com.
Dr. Della Valle’s Study wins MAOA Poster Award
Dr. Della Valle’s study entitled “A Multi-center Randomized Clinical Trial of Tranexamic Acid in Revision Total Knee Arthroplasty: Does the Dosing Regimen Matter?” was selected as one of two posters to win the Poster Award at the 2019 Mid-America Orthopaedic Association annual meeting.
For more information on MAOA, please visit www.maoa.org.
Dr. Della Valle’s Paper Wins The Knee Society’s Mark Coventry, MD Award
Dr. Della Valle’s paper entitled, “A Multi-center Randomized Clinical Trial of Tranexamic Acid in Revision Total Knee Arthroplasty: Does the Dosing Regimen Matter?” has won The Knee Society’s Mark Coventry, MD Award.
Revision total knee arthroplasty is a complex surgery that has a higher risk of blood loss than primary total knee arthroplasty. In this multi-center, prospective, randomized controlled trial we evaluated different dosing and administration routes of tranexamic acid, a medication shown to reduce blood loss after primary and revision total knee arthroplasty. This study found that all tranexamic dosing regimens were similarly effective methods of blood management in revision total knee arthroplasty. This study supports that surgeons should consider using the lowest effective dose and the least costly regimen for tranexamic acid use in revision total knee arthroplasty.
The paper will be presented at The Knee Society/AAHKS Specialty Day program (AAOS 2019 Annual Meeting) on Saturday, March 16, in Las Vegas, NV.
Videos from a Hip Replacement Patient
“Thanks again for another successful resurfaced hip. I now have both hips resurfaced, and I feel almost at full strength after 8 months. My wife took a video of me running to first base tonight. Don’t pay attention to the terrible swing on that pitch, but instead on my legs moving pretty well to beat out the infield hit. I’d say not bad for a 49 year old with 2 metal hips! I also stole second base after that. I will definitely recommend you to any player who is told he needs hip surgery. Thank you for giving me my life back. I will be playing every year in the Roy Hobbs World Series down in Fort Myers, Florida at the end of October for 2 weeks thanks to you.”
– Mike D., Hip Replacement Patient
Dr. Della Valle’s Presentation chosen for inclusion in the Best of AAOS
One of Dr. Della Valle’s recent presentations, entitled “Hypoalbuminemia Predicts Joint Infection, Pneumonia, and Readmission After Total Joint Arthroplasty”, has been chosen by the American Academy of Orthopaedic Surgeons (AAOS) for inclusion in their Best of AAOS presentation. The Best of AAOS presentation will take place Friday, March 4, at the AAOS Annual Meeting in Orlando, FL.
Dr. Della Valle recipient of The Mark Coventry, MD Award
Dr. Della Valle has been selected as the recipient of The Mark Coventry, MD Award for his paper titled, “Oral Antibiotics Reduce Reinfection Following 2-Stage Exchange: A Multi-Center, Randomized Controlled Trial.”.
He will present the paper at The Knee Society/AAHKS Specialty Day program (AAOS 2016 Annual Meeting) on Saturday, March 5, 2016, in, Orlando, FL.
Dr. Della Valle’s study wins The James A. Rand Young Investigator’s Award
A recent study that Dr. Della Valle co-authored has won The James A. Rand Young Investigator’s Award. The study is entitled “A Randomized Controlled Trial Of Oral And IV Tranexamic Acid: The Same Efficacy At Lower Cost?”. The award will be presented on November 7th at the annual AAHKS meeting in Dallas, TX.
About the award
The American Association of Hip and Knee Surgeons (AAHKS) established the Young Investigator’s Award in honor of James A. Rand, MD, founding member and past president of AAHKS. The purpose of the Award is to recognize a young investigator who demonstrates clinical excellence in knee-related research.
To be eligible, the young researcher must be the principal investigator of the research submitted, and less than five years in active practice from the date of application.
The most outstanding paper that embodies Dr. Rand’s commitment to the highest standards of orthopaedic knowledge will be selected for presentation at the Annual Meeting.
About the study
Blood loss is a concern after hip and knee arthroplasty. Tranexamic acid, is a medication that is used commonly to reduce blood loss and the risk of transfusion after surgery. Tranexamic acid is usually given intravenously at the time of surgery.
In this study, we compared the use of an oral formulation of tranexamic acid to the IV form. The oral form is much less expensive and we found in this study that the oral form was just as effective. This study could lead to substantial cost savings for our health care system, in the range of $50 million dollars per year given that nearly 1,000,000 hip and knee replacements are performed in the United States every year.
Click here to learn more about the award »
Click here to read the study’s abstract »
